Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-25-000807

Chief Discovery/Trans Medicine sold 32,729 shares at an average $19.82 ($648,824)

  • Chief Discovery/Trans Medicine acquired 100,000 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hamilton James C Chief Discovery/Trans Medicine 2025-01-04 Grant or award 10b5-1 +100,000 304,851 D: show line 1 in the form
Hamilton James C Chief Discovery/Trans Medicine 2025-01-06 Sale 10b5-1 −21,758 $19.68 $428,197 283,093 D: show line 2 in the form
Hamilton James C Chief Discovery/Trans Medicine 2025-01-06 Sale 10b5-1 −10,971 $20.11 $220,627 272,122 D: show line 3 in the form
Open-market sales · 32,729 sh · avg $19.82 · $648,824
Loading xslF345X05/wk-form4_1736303292.xml…